Source:http://linkedlifedata.com/resource/pubmed/id/15643606
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-1-17
|
pubmed:databankReference | |
pubmed:abstractText |
Hirschsprung disease (HSCR) is a complex genetic defect of intestinal innervation mainly ascribed to loss of function mutations of the RET gene. Although RETcoding mutations account for only 15% of HSCR sporadic cases, several linkage and association studies still indicate RET as a major HSCR gene, suggesting the existence of noncoding RET variants or common polymorphisms which can act in HSCR pathogenesis. We previously described a predisposing RET haplotype (A-C-A) composed of alleles at three SNPs (-1 bp and -5 bp from the RET transcription start site, NT_033985.6:g.975824G>A and NT_033985.6:g.975820C>A, respectively, and silent polymorphism c.135G>A), which was present in 62% of chromosomes from HSCR patients but only in 22% of control chromosomes. Here we address the question of how this 5' ACA haplotype may functionally act as a predisposing factor in HSCR pathogenesis by performing functional analysis of the same three SNPs. We demonstrate that neither the two promoter variants nor the exon 2 SNP interfere with reporter gene transcription or RET mRNA splicing, respectively. However, real-time RT-PCR, performed in RNA obtained from lymphoblasts of selected individuals, has shown that homozygosity for the whole ACA haplotype is associated with reduced RET gene expression. We propose that a yet unidentified variant in linkage disequilibrium with the ACA haplotype, rather than the single characterizing SNPs, acts as a HSCR susceptibility allele by affecting the normal amount of RET receptor on the cell surface.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1098-1004
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
189-95
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15643606-5' Flanking Region,
pubmed-meshheading:15643606-Cells, Cultured,
pubmed-meshheading:15643606-Exons,
pubmed-meshheading:15643606-Female,
pubmed-meshheading:15643606-Gene Expression,
pubmed-meshheading:15643606-Genetic Predisposition to Disease,
pubmed-meshheading:15643606-Haplotypes,
pubmed-meshheading:15643606-Hirschsprung Disease,
pubmed-meshheading:15643606-Homozygote,
pubmed-meshheading:15643606-Humans,
pubmed-meshheading:15643606-Male,
pubmed-meshheading:15643606-Polymorphism, Single Nucleotide,
pubmed-meshheading:15643606-Promoter Regions, Genetic,
pubmed-meshheading:15643606-Proto-Oncogene Proteins c-ret,
pubmed-meshheading:15643606-RNA, Messenger,
pubmed-meshheading:15643606-RNA Splicing
|
pubmed:year |
2005
|
pubmed:articleTitle |
A common haplotype at the 5' end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression.
|
pubmed:affiliation |
Laboratorio di Genetica Molecolare, Istituto G. Gaslini, Genova, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|